These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1056 related articles for article (PubMed ID: 3937715)

  • 41. Chemical synthesis, cloning and expression in mammalian cells of a gene coding for human tissue-type plasminogen activator.
    Bell LD; Smith JC; Derbyshire R; Finlay M; Johnson I; Gilbert R; Slocombe P; Cook E; Richards H; Clissold P
    Gene; 1988 Mar; 63(2):155-63. PubMed ID: 2838384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stable production of an analog of human tissue plasminogen activator from cultured Drosophila cells.
    Olsen MK; Rockenbach SK; Fischer HD; Hoogerheide JG; Tomich CS
    Cytotechnology; 1992; 10(2):157-67. PubMed ID: 1369211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nucleotide sequence of the tissue-type plasminogen activator cDNA from human fetal lung cells.
    Sasaki H; Saito Y; Hayashi M; Otsuka K; Niwa M
    Nucleic Acids Res; 1988 Jun; 16(12):5695. PubMed ID: 3133640
    [No Abstract]   [Full Text] [Related]  

  • 44. Preparation of antisera to recombinant, soluble N-acetylglucosaminyltransferase V and its visualization in situ.
    Chen L; Zhang N; Adler B; Browne J; Freigen N; Pierce M
    Glycoconj J; 1995 Dec; 12(6):813-23. PubMed ID: 8748159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LAK cells release a novel form of directly acting TGF beta, tightly bound to a high molecular weight carrier(s).
    Larisch-Bloch S; Sulitzeanu D
    Growth Factors; 1993; 8(3):177-86. PubMed ID: 7686383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of the co-stimulatory molecule B7 on melanoma cells.
    Hersey P; Si Z; Smith MJ; Thomas WD
    Int J Cancer; 1994 Aug; 58(4):527-32. PubMed ID: 7520026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spirogermanium: a new investigational drug of novel structure and lack of bone marrow toxicity.
    Slavik M; Blanc O; Davis J
    Invest New Drugs; 1983; 1(3):225-34. PubMed ID: 6678870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antitumor effects of recombinant human leukocyte interferon (rIFN-alpha A) on human malignomas transplanted into nude mice].
    Hashizume S
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):284-8. PubMed ID: 3970552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sinus histiocytosis mimicking metastatic melanoma in lymph nodes of a patient with a large joint prosthesis: case report and review of the literature.
    Charny CK; Jacobowitz G; Melamed J; Tata M; Harris MN
    J Surg Oncol; 1995 Oct; 60(2):128-30. PubMed ID: 7564379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Review of melanoma antigens recognized by monoclonal antibodies (MAbs). Their functional significance and applications in diagnosis and treatment of melanoma.
    Hersey P
    Pathology; 1985 Apr; 17(2):346-54. PubMed ID: 4047738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Malignant melanoma: reduced risk associated with early childbearing and multiparity.
    Lambe M; Thörn M; Sparén P; Bergström R; Adami HO
    Melanoma Res; 1996 Apr; 6(2):147-53. PubMed ID: 8791273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose.
    Hoh CK; Hawkins RA; Glaspy JA; Dahlbom M; Tse NY; Hoffman EJ; Schiepers C; Choi Y; Rege S; Nitzsche E
    J Comput Assist Tomogr; 1993; 17(4):582-9. PubMed ID: 8331230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Circulating immune complexes in the serum of tumor patients].
    Alvarez R; García Gómez A; Subiza JL; Domínguez J; Bootello A; Coll J
    Rev Esp Oncol; 1982; 29(4):727-34. PubMed ID: 6927370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro cell-mediated immune responses induced by a polyvalent allogeneic melanoma vaccine.
    Adler A; Oraz R; Bystryn JC
    Cancer Biother; 1995; 10(3):211-24. PubMed ID: 8547960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cervical nodal metastases of unknown origin.
    Barrie JR; Knapper WH; Strong EW
    Am J Surg; 1970 Oct; 120(4):466-70. PubMed ID: 5507332
    [No Abstract]   [Full Text] [Related]  

  • 56. Tumor-associated antigens in gynecologic cancer.
    DiSaia PJ
    Clin Obstet Gynecol; 1975 Dec; 18(4):87-108. PubMed ID: 765038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acquired homozygosity (isodisomy) of chromosome 3 during clonal evolution of a uveal melanoma: association with morphologic heterogeneity.
    White VA; McNeil BK; Thiberville L; Horsman DE
    Genes Chromosomes Cancer; 1996 Feb; 15(2):138-43. PubMed ID: 8834179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Morphologic analysis of three-dimensional tumors developed in fibrin matrix and agar culture system.
    Kumazawa H; Hess M; Koldovsky P
    Pathobiology; 1993; 61(1):31-5. PubMed ID: 8216820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Knowledge of malignant melanoma and how it relates to clinical practice among nurse practitioners and dermatology and oncology nurses.
    Maguire-Eisen M; Frost C
    Cancer Nurs; 1994 Dec; 17(6):457-63. PubMed ID: 7820823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity.
    Goldstein AM; Dracopoli NC; Ho EC; Fraser MC; Kearns KS; Bale SJ; McBride OW; Clark WH; Tucker MA
    Am J Hum Genet; 1993 Mar; 52(3):537-50. PubMed ID: 8447320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.